Evgeniya Makarova
Senior Vice President, Industrial Operations and Product Supply Finance and Business OperationsRegeneron Pharmaceuticals
PharmaceuticalsView Profile →Head of Capital Markets and Investor Relations · Viatris
Bill Szablewski is head of capital markets and investor relations at Viatris. His pharmaceutical finance experience includes treasury, capital markets and investor communications at Bristol Myers Squibb.
Last reviewed: Oct 21, 2026
Head of Capital Markets and Investor Relations
Viatris
Last Reviewed: October 21, 2026
Bill Szablewski is head of capital markets and investor relations at Viatris. His pharmaceutical finance experience includes treasury, capital markets and investor communications at Bristol Myers Squibb.
At Bristol Myers Squibb, Szablewski’s investor relations work included executive support, investor communications strategy and international shareholder outreach. He subsequently served as assistant treasurer for capital markets, managing relationships with banks, rating agencies and fixed income investors. His work supported financing and the shareholder vote for the Celgene acquisition.
Mylan announced his appointment in November 2020, ahead of Viatris’ launch. The assignment included building relationships across equity and debt markets and overseeing investor relations and treasury within the finance leadership team.
Szablewski remained a public representative of Viatris’ investment case in 2026. At the company’s March 19 investor event, he identified his role as head of capital markets and investor relations, outlined the presentation’s forward-looking-statement context and introduced the executive team. The company also identified him as its investor contact in its August 2026 financial results announcement.
Szablewski earned an MBA from Drexel University and a bachelor’s degree from Virginia Tech. He is a CFA charterholder.